Inactivated polio vaccine (IPV) and Diphtheria-Tetanus-Pertussis vaccine (DTaP) / 2024-2025

Finnish Institute for Health and Welfare, later referred to as THL, request your tender for Inactivated polio vaccine (IPV) and Diphtheria-Tetanus-Pertussis vaccine (DTaP) to the rescEU project. The Scope of procurement is described in more detail in Annex 1. The procurement is divided in two (2) lots. Tender may be submitted for one or several lots. - LOT 1: Inactivated polio vaccine (IPV), suspension for injection - LOT 2: Diphtheria-Tetanus-Pertussis vaccine (DTaP), suspension for injection in prefilled syringe The minimum requirements for the articles is described in Annex 1.1. The contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the contract has been signed by contracting parties and expires when all contractual duties of the contract have been performed. Estimated quantity for the product in described in Annex 6 (restricted to security classification level IV, TL IV). Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Contract Annex 3 Security annex Annex 4 Description of the Handi service Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 6 Estimated quantity (restricted, TL IV) Annex 7 Confidentiality commitment Please note that the numbering of the annexes differs between the Contract and the Call for Tenders.

The availability for the Annex 6 is restricted to security classification level IV (TL IV). THL will send the restricted Annex 6 to a representative of the tenderer via encrypted email after THL has received the signed confidentiality commitment (Annex 7). Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "THL/5527/2.02.06/2023 / Inactivated polio vaccine (IPV) and Diphtheria-Tetanus-Pertussis vaccine (DTaP) / 2024-2025". The message must contain name of the tenderer and email address to which the restricted Annex 6 is to be sent.